154 related articles for article (PubMed ID: 27208502)
21. Potential roles of BMP9 in liver fibrosis.
Bi J; Ge S
Int J Mol Sci; 2014 Nov; 15(11):20656-67. PubMed ID: 25393508
[TBL] [Abstract][Full Text] [Related]
22. Homeobox D3, A Novel Link Between Bone Morphogenetic Protein 9 and Transforming Growth Factor Beta 1 Signaling.
Wang L; Yao J; Yu T; Zhang D; Qiao X; Yao Z; Wu X; Zhang L; Boström KI; Yao Y
J Mol Biol; 2020 Mar; 432(7):2030-2041. PubMed ID: 32061928
[TBL] [Abstract][Full Text] [Related]
23. Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting.
van Meeteren LA; Thorikay M; Bergqvist S; Pardali E; Stampino CG; Hu-Lowe D; Goumans MJ; ten Dijke P
J Biol Chem; 2012 May; 287(22):18551-61. PubMed ID: 22493445
[TBL] [Abstract][Full Text] [Related]
24. A Bone Morphogenetic Protein (BMP)-derived Peptide Based on the Type I Receptor-binding Site Modifies Cell-type Dependent BMP Signalling.
Tong Z; Guo J; Glen RC; Morrell NW; Li W
Sci Rep; 2019 Sep; 9(1):13446. PubMed ID: 31530856
[TBL] [Abstract][Full Text] [Related]
25. Exogenous BMP9 promotes lung fibroblast HFL-1 cell activation via ALK1/Smad1/5 signaling
Wang Y; Sima X; Ying Y; Huang Y
Exp Ther Med; 2021 Jul; 22(1):728. PubMed ID: 34007337
[TBL] [Abstract][Full Text] [Related]
26. RUNX1 Plays an Important Role in Mediating BMP9-Induced Osteogenic Differentiation of Mesenchymal Stem Cells Line C3H10T1/2, Murine Multi-Lineage Cells Lines C2C12 and MEFs.
Ji C; Liu X; Xu L; Yu T; Dong C; Luo J
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28644396
[TBL] [Abstract][Full Text] [Related]
27. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling.
Goumans MJ; Valdimarsdottir G; Itoh S; Lebrin F; Larsson J; Mummery C; Karlsson S; ten Dijke P
Mol Cell; 2003 Oct; 12(4):817-28. PubMed ID: 14580334
[TBL] [Abstract][Full Text] [Related]
28. Endoglin promotes TGF-β/Smad1 signaling in scleroderma fibroblasts.
Morris E; Chrobak I; Bujor A; Hant F; Mummery C; Ten Dijke P; Trojanowska M
J Cell Physiol; 2011 Dec; 226(12):3340-8. PubMed ID: 21344387
[TBL] [Abstract][Full Text] [Related]
29. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
30. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
31. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.
Ricard N; Ciais D; Levet S; Subileau M; Mallet C; Zimmers TA; Lee SJ; Bidart M; Feige JJ; Bailly S
Blood; 2012 Jun; 119(25):6162-71. PubMed ID: 22566602
[TBL] [Abstract][Full Text] [Related]
32. BMP9 Induces Cord Blood-Derived Endothelial Progenitor Cell Differentiation and Ischemic Neovascularization via ALK1.
Kim J; Kim M; Jeong Y; Lee WB; Park H; Kwon JY; Kim YM; Hwang D; Kwon YG
Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):2020-31. PubMed ID: 26229139
[TBL] [Abstract][Full Text] [Related]
33. Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex.
Townson SA; Martinez-Hackert E; Greppi C; Lowden P; Sako D; Liu J; Ucran JA; Liharska K; Underwood KW; Seehra J; Kumar R; Grinberg AV
J Biol Chem; 2012 Aug; 287(33):27313-25. PubMed ID: 22718755
[TBL] [Abstract][Full Text] [Related]
34. Intracellular TGF-beta receptor blockade abrogates Smad-dependent fibroblast activation in vitro and in vivo.
Ishida W; Mori Y; Lakos G; Sun L; Shan F; Bowes S; Josiah S; Lee WC; Singh J; Ling LE; Varga J
J Invest Dermatol; 2006 Aug; 126(8):1733-44. PubMed ID: 16741519
[TBL] [Abstract][Full Text] [Related]
35. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
36. Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation.
Herrera B; van Dinther M; Ten Dijke P; Inman GJ
Cancer Res; 2009 Dec; 69(24):9254-62. PubMed ID: 19996292
[TBL] [Abstract][Full Text] [Related]
37. BMP9 attenuates occurrence of venous malformation by maintaining endothelial quiescence and strengthening vessel walls via SMAD1/5/ID1/α-SMA pathway.
Li Y; Shang Q; Li P; Yang Z; Yang J; Shi J; Ge S; Wang Y; Fan X; Jia R
J Mol Cell Cardiol; 2020 Oct; 147():92-107. PubMed ID: 32730768
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor (TGF)-β type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.
Piao S; Choi MJ; Tumurbaatar M; Kim WJ; Jin HR; Shin SH; Tuvshintur B; Yin GN; Song JS; Kwon MH; Lee SJ; Han JY; Kim SJ; Ryu JK; Suh JK
J Sex Med; 2010 Oct; 7(10):3385-95. PubMed ID: 20233292
[TBL] [Abstract][Full Text] [Related]
39. SEMA3G regulates BMP9 inhibition of VEGF-mediated migration and network formation in pulmonary endothelial cells.
Mirza SL; Upton PD; Hodgson J; Gräf S; Morrell NW; Dunmore BJ
Vascul Pharmacol; 2024 Jun; 155():107381. PubMed ID: 38795838
[TBL] [Abstract][Full Text] [Related]
40. BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain.
Bidart M; Ricard N; Levet S; Samson M; Mallet C; David L; Subileau M; Tillet E; Feige JJ; Bailly S
Cell Mol Life Sci; 2012 Jan; 69(2):313-24. PubMed ID: 21710321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]